JACKIE SHUMATE: Open Payments
NPI 1558600221 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,066 in 261 payments from 21 companies in 2025. Trend: 2023 $3,734 · 2024 $4,438 · 2025 $5,066
Food & beverage: $5,066
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 72 | $1,346 |
| Janssen Biotech, Inc. | 38 | $690 |
| Ardelyx, Inc. | 22 | $566 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 37 | $536 |
| GENZYME CORPORATION | 11 | $307 |
| Madrigal Pharmaceuticals | 13 | $301 |
| Ipsen Biopharmaceuticals, Inc | 14 | $232 |
| Phathom Pharmaceuticals, Inc. | 8 | $206 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $190 |
| PFIZER INC. | 10 | $156 |
Products named: TREMFYA, IBSRELA, SKYRIZI, DUPIXENT, RINVOQ, REZDIFFRA, XIFAXAN, LINZESS.
Industry payments across AL — which companies pay providers there.
